HAEMONETICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.8 USD | -1.75% |
|
+2.38% | +10.86% |
| May. 10 | Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating | MT |
| May. 09 | Haemonetics Seeks Acquisitions | CI |
Presenter SpeechGerard Gould (Executives)Well, good morning, everybody, and welcome. Thank you...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.
Calendar
2024-08-05
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
94.8
USD
Average target price
112.5
USD
Spread / Average Target
+18.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.86% | 4.81B | |
| -4.72% | 182B | |
| +3.96% | 114B | |
| -2.93% | 68.38B | |
| +6.30% | 52.46B | |
| +8.02% | 44.25B | |
| +7.52% | 43.55B | |
| +26.18% | 32.69B | |
| +17.85% | 26.73B | |
| +0.57% | 25.79B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Transcript : Haemonetics Corporation - Analyst/Investor Day